StockWatch
·
Pharmacy Retail
Regulatory31 May 2026, 06:01 pm

Medplus Subsidiary Receives Drug License Suspension Orders

AI Summary

Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services Ltd, received two suspension orders for drug licenses of stores in Telangana. The first order, received on May 30, 2026, suspends the license for five days, potentially resulting in a revenue loss of ₹0.85 lacs. The second order suspends a license for two days, leading to a potential revenue loss of ₹0.18 lacs. The company has disclosed this information under Regulation 30 of SEBI guidelines.

Key Highlights

  • Medplus subsidiary, Optival Health, receives two drug license suspension orders.
  • First suspension: 5 days, potential revenue loss of ₹0.85 lacs.
  • Second suspension: 2 days, potential revenue loss of ₹0.18 lacs.
  • Suspensions relate to stores in Nalgonda and Serilingampali, Telangana.
  • Disclosure made under SEBI Regulation 30.